Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
PremiumPress ReleasesVeru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
1M ago
Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
PremiumPress Releases
Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
1M ago
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
PremiumPress Releases
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
2M ago
Veru to Present at the GLP-1 Based Therapeutics Summit
PremiumPress ReleasesVeru to Present at the GLP-1 Based Therapeutics Summit
3M ago
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
PremiumPress Releases
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
3M ago
Veru enrolls first patients in Phase 2b trial of enobosarm, semaglutide
PremiumThe Fly
Veru enrolls first patients in Phase 2b trial of enobosarm, semaglutide
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100